News

Two Seas Capital moves to block CoreWeave’s $9B all-stock deal for Core Scientific, citing low valuation and high risk.
Two Seas Capital opposes Core Scientific's all-stock acquisition by CoreWeave, citing undervaluation and risk.
Two Seas Capital LP, the largest active shareholder of Core Scientific, Inc., announced Thursday its opposition to the ...
Two Seas Capital has come out against Core Scientific's proposed all-stock acquisition by AI cloud provider CoreWeave.
Two Seas Capital claims to own 6.3% of Core Scientific’s outstanding stock. While Vanguard and Blackrock are the largest ...
Core Scientific's largest shareholder, Two Seas Capital LP, has announced its opposition to the $9bn acquisition proposed by ...
Two Seas Capital is challenging Core Scientific’s $9 billion sale to CoreWeave, arguing the terms significantly undervalue ...
Two Seas Capital opposes CoreWeave’s acquisition of Core Scientific, citing shareholder risk and sparking debate on AI infrastructure deals.
CoreWeave’s acquisition of Core Scientific is facing shareholder pushback, sparking a rally in AI tokens and centralization questions.
Two Seas Capital, the largest shareholder of Core Scientific , issued an open letter on Thursday saying it would vote against ...
Coinbase raises $2B in convertible notes, Core Scientific shareholder opposes $9B CoreWeave merger, and Block adds 108 ...
CoreWeave has fallen by roughly a third since its June peak. Strong earnings from fellow AI cloud company Nebius could soothe ...